Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Andrographis paniculata extract × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Squamous Cell Carcinoma 1

Interventions

Cyclophosphamide 1791 Radiotherapy 1754 Cisplatin 1592 Carboplatin 1350 Gemcitabine 1252 Paclitaxel 1153 Bevacizumab 1131 Docetaxel 1081 pembrolizumab 1078 Capecitabine 1035 Oxaliplatin 1024 Fluorouracil 961 Dexamethasone 855 Magnetic Resonance Spectroscopy 846 Nivolumab 818 Rituximab 808 Drug Therapy 778 Surveys and Questionnaires 771 Doxorubicin 733 Etoposide 725 Radiosurgery 707 Blood Specimen Collection 704 Irinotecan 683 Cytarabine 650 fludarabine 634 Leucovorin 606 Surgical Procedures, Operative 552 Lenalidomide 548 Biopsy 507 Radiation 503

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04196075 2021-11-08

AP

Chinese University of Hong Kong

Phase 3 Completed

Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡